Mononuclear phagocytes in tuberculosis pathogenesis

Current Opinion in Infectious Diseases

Volumn 10, Issue 3, 1997, Pages 190-195

  Ferguson, J Scott ^a   Gaynor, Cecilia D ^a   Schlesinger, Larry S ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL GROWTH; CELL INTERACTION; CELL KILLING; EPITHELIUM CELL; GRANULOMA; HOST CELL; MACROPHAGE; MEDIATOR; MYCOBACTERIUM TUBERCULOSIS; PATHOGENESIS; PHAGOSOME; REVIEW; SURVIVAL; TUBERCULOSIS;

EID: 0030915906     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-199706000-00006     Document Type: Review

References (50)

1. Schlesinger LS: Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J Immunol 1993, 150:2920-2930.
2. Hirsch CS, Ellner JJ, Russell DG, Rich EA: Complement receptor-mediated uptake and tumor necrosis factor-alpha-mediated growth inhibition of Mycobacterium tubercufosis by human alveolar macrophages. J Immunol 1994, 152:743-753.
3. Stokes RW, Haidl ID, Jefferies WA, Speert DP: Mycobacteria-macrophage interactions: Macrophage phenotype determines the non-opsonic binding of Mycobacterium tuberculosis to murine macrophages. J Immunol 1993, 151:7067-7076.
4. Schlesinger LS, Bellinger-Kawahara GC, Payne NR, Horwitz MA: Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. J Immunol 1990, 144:2771-2780.
5. Cywes C, Godenir NL, Hoppe HC, Scholle RR, Steyn LM, Kirsch RE, Ehlers MRW: Non-opsonic binding of Mycobacterium tuberculosis to human complement receptor type 3 expressed in Chinese hamster ovary cells. Infect Immun 1996, 64: 5373-5383.
6. Schlesinger LS, Hull SR, Kaufman TM: Binding of the terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages. J Immunol 1994, 152:4070-4079.
7. Schlesinger LS, Kaufman TM, Iyer S, Hull SR, Marciando LK: Differences in mannose receptor-mediated uptake of lipoarabinomannan from virulent and attenuated strains of Mycobacterium tuberculosis by human macrophages. J Immunol 1996, 157:4568-4575.
8. Peterson PK, Gekker G, Hu S, Sheng WS, Anderson WR, Ulevitch RJ, Tobias PS, Gustafson KV, Molitor TW, Chao CC: CD14 receptor-mediated uptake of nonopsonized Mycobacterium tuberculosis by human microglia. Infect Immun 1995, 63:1598-1602.
9. Khanna KV, Choi CS, Gekker G, Pelerson PK, Molitor TW: Differential infection of porcine alveolar macrophage subpopulations by non-opsonized Mycobacterium bovis involves CD14 receptors. J Leukoc Biol 1996, 60:214-220.
10. Zimmerli S, Edwards S, Ernst JD: Selective receptor blockade during phagocytosis does not alter the survival and growth of Mycobacterium tuberculosis in human macrophages. Am J Respir Cell Molec Biol 1996, 15:760-770.
11. Arruda S, Bomfim G, Knights R, Huima-Byron T, Riley LW: Cloning of an M. tuberculosis DNA fragment associated with entry and survival inside cells. Science 1993, 261:1454-1457.
12. Goswami S, Sarkar S, Basu J, Kundu M, Chakrabarti P: Mycotin: a lectin involved in the adherence of Mycobacteria to macrophages. FEBS Lett 1994, 355:183-186.
13. Menozzi FD, Rouse JH, Alavi M, Laude-Sharp M, Muller J, Bischoff R, Brennan MJ, Locht C: Identification of a heparin-binding hemagglutinin present in mycobacteria. J Exp Med 1996, 184: 993-1001. In this study, the authors isolated a previously unrecognized surface-exposed 28 000 M, heparin-binding hemagglutinin from M. bows BCG and H37Ra M. tuberculosis, Monoclonal antibodies that recognize the protein demonstrate that it is present on the surface of H37Ra M. tuberculosis. This protein mediates mycobacterial aggregation and the adherence of mycobacteria to Chinese hamster ovary cells.
14. Aung H, Toossi Z, Wisnieski JJ, Wallis RS, Culp LA, Phillips NB, Phillips M, Averill LE, Daniel TM, Ellner JJ: Induction of monocyte expression of tumor necrosis factor α by the 30-kD α antigen of Mycobacterium tuberculosis and synergism with fibronectin. J Clin Invest 1996, 98: 1261-1268.
15. Kusner DJ, Hall CF, Schlesinger LS: Activation of macrophage phospholipase D is tightly coupled to the phagocytosis of Mycobacterium tuberculosis or opsonized zymosan by human macrophages. J Exp Med 1996, 184:585-595. The authors provide evidence for the activation of PLD during phagocytosis of the Erdman and H37Ra strains of M. tuberculosis by MDMs. Inhibition of PLD activity results in reduced phagocytosis of bacteria, indicating that these processes may be linked and that activation of PLD may regulate bacterial ingestion, M. tuberculosis phagocytosis also results in rapid and sustained increases in tyrosine phosphorylation of multiple MDM proteins, Protein tyrosine kinases may thus be involved in the PLD activity.
16. Fulton SA, Johnsen JM, Wolf SF, Sieburth DS, Boom WH: Interleukin-12 production by human monocytes infected with Mycobacterium tuberculosis: role of phagocytosis. Infect Immun 1996, 64:2523-2531.
17. Gaynor CD, McCormack FX, Voelker DR, McGowan SE, Schlesinger LS: Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages. J Immunol 1995, 155:5343-5351.
18. Downing JF, Pasula R, Wright JR, Twigg HL, III, Martin WJ, II: Surfactant protein A promotes attachment of Mycobacterium tuberculosis to alveolar macrophages during infection with human immunodeficiency virus. Proc Natl Acad Sci USA 1995, 92:4848-4852.
19. Sturgill-Koszycki S, Schlesinger PH, Chakraborty P, Haddix PL, Collins HL, Fok AK, Allen RD, Gluck SL, Heuser J, Russell DG: Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science 1994, 263:678-681.
20. Harth G, Clemens DL, Horwitz MA: Glutamine synthetase of Mycobacterium tuberculosis: extracellular release and characterization of its enzymatic activity. Proc Natl Acad Sci USA 1994, 91:9342-9346.
21. Clemens DL, Lee BY, Horwitz MA: Purification, characterization, and genetic analysis of Mycobacterium tuberculosis urease, a potentially critical determinant of host-pathogen interaction. J Bactenol 1995, 177:5644-5652.
22. Xu S, Cooper A, Sturgill-Koszycki S, Van Heyningen T, Chatterjee D, Orme I, Allen P, Russell DG: Intracellular trafficking in Mycobacterium tuberculosis and Mycobacterium avium-infected macrophages. J Immunol 1994, 153:2568-2578.
23. Clemens DL, Horwitz MA: Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited. J Exp Med 1995, 181:257-270.
24. Clemens DL, Hortitz MA: The Mycobacterium tuberculosis phagosome interacts with early endosomes and is accessible to exogenously administered transferrin. J Exp Med 1996, 184:1349-1355. Using cryosection immunogold labelling techniques, the authors demonstrated that phagosomes containing live M. tuberculosis acquire exogenously administered transferrin, a marker for early endosomes. This study shows that the M. tuberculosis phagosome can fuse with early endosomes, providing a potential targeted approach to antimicrobial therapy.
25. Russell DG, Dant J, Sturgill-Koszycki S: Mycobacterium avium- and Mycobacterium tuberculosis-containing vacuoles are dynamic, fusion-competent vesicles that are accessible to glycosphingolipids from the host cell plasmalemma. J Immunol 1996, 156:4764-4773. Using cholera toxin B subunit which binds to GM1 ganglioside on the macrophage plasmalemma, the authors demonstrated that mycobacteria-containing phagosomes rapidly acquire these markers. This study indicates that the M. tuberculosis phagosome can acquire markers from the cell surface, and that this pathway is distinct from that of fluid-phase markers.
26. Barnes PF, Modlin RL, Shinnick TM (Eds): Tuberculosis, In Human cellular immune responses to Mycobacterium tuberculosis. New York: Springer; 1996: 197-219.
27. Mazzaccaro RJ, Gedde M, Jensen ER, Van Santen HM, Pleogh HL, Rock KL, Bloom BR: Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection. Proc Natl Acad Sci USA 1996, 93: 11786-11791. The authors provide evidence that infection of a murine bone marrow macrophage clone with live virulent M. tuberculosis allows for the specific recognition of soluble ovalbumin epitopes by a MHC class I-restricted ovalbumin-specific cytotoxic T-lymphocyte hybridoma. This study thus indicates that M. tuberculosis provides access of a soluble antigen from the endocytic compartment to the macrophage MHC class I pathway. All of the MHC class I presentation of albumin facilitated by M. tuberculosisinfected macrophages was TAP-dependent.
28. Barker K, Fan HX, Carroll C, Kaplan G, Barker J, Hellmann W, Cohn ZA: Nonadherent cultures of human monocytes kill Mycobacterium smegmatis, but adherent cultures do not. Infect Immun 1996, 64:428-433.
29. Paul S, Laochumroonvorapong P, Kaplan G: Comparable growth of virulent and avirulent Mycobacterium tuberculosis in human macrophages in vitro. J Infect Dis 1996, 174:105-112.
30. Nicholson S, Bonecini-Almeida MDG, Silva JRLE, Nathan C, Xie QW, Mumford R, Weidner JR, Calaycay J, Geng J, Boechat N et al. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J Exp Med 1996, 183:2293-2302. The authors used a novel monospecific antibody to human inducible nitric oxide synthase to detect nitric oxide synthase protein which was catalytically competent in human alveolar macrophages from patients with active TB.
31. D'Souza S, Levin M, Faith A, Yssel H, Bennett B. Lake RA, Brown IN, Lamb JR: Defective antigen processing associated with familial disseminated mycobacteriosis. Clin Exp Immunol 1996, 103:35-39.
32. Frucht DM, Holland SM: Defective monocyte costimulation for IFN-gamma production in familial disseminated Mycobacterium avium complex infection - abnormal IL-12 regulation. J Immunol 1996, 157:411-416.
33. s mouse strains. The authors provide an excellent discussion on the current status of Nramp genes and gene products in immunity to intracellular pathogens.
34. s mice. This report thus suggests that unlike susceptibility to M. bovis, Nramp1 does not confer resistance to M. tuberculosis.
35. 2 induces monocyte apoptosis and reduces viability of Mycobacterium avium-M-intracellulare within cultured human monocytes. Infec Immun 1996, 64:452-459.
36. Molloy A, Laochumroonvorapong P, Kaplan G: Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guérin. J Exp Med 1994, 180:1499-1509.
37. Keane J, Balcewicz-Sablinska MK, Remold HG, Chupp GL, Meek BB, Fenton MJ, Kornfeld H Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis. Infect Immun 1997, 65:298-304.
38. Bermudez LE, Petrofsky M, Shelton K: Epidermal growth factorbinding protein in Mycobacterium avium and Mycobacterium tuberculosis: a possible role in the mechanism of infection. Infect Immun 1996, 64:2917-2922.
39. Bange FC, Brown AM, Jacobs WR Jr: Leucine auxotrophy restricts growth of Mycobacterium bovis BCG in macrophages. Infect Immun 1996, 64:1794-1799.
40. Rhoades ER, Cooper AM, Orme IM: Chemokine response in mice infected with Mycobacterium tuberculosis. Infect Immun 1995, 63:3871-3877.
41. + T cell counts have impaired Th1 responses. J Immunol 1997, 158:492-500.
42. Ilangumaran S, Ami S, Poincelet M, Theler J-M, Brennan PJ, Din N, Hoessli DC: Integration of mycobacterial lipoarabinomannans into glycosylphosphatidylinositol-rich domains of lymphomonocytic cell plasma membranes. J Immunol 1995, 155:1334-1342.
43. Stokes RW, Speert DP: Lipoarabinomanan inhibits non-opsonic binding of Mycobacterium tuberculosis to murine macrophages. J Immunol 1995, 155:1361-1369.
44. Brennan PJ, Nikaido H: The envelope of mycobacteria. Annu Rev Biochem 1995, 64:29-63.
45. Dahl KE Shiratsuchi H, Hamilton BD, Ellner JJ, Toossi Z: Selective induction of transforming growth factor β in human monocytes by lipoarabinomannan of Mycobacterium tuberculosis. Infec Immun 1996, 64:399-405.
46. Berman JS, Blumenthal RL, Kornfeld H, Cook JA, Cruikshank WW, Vermeulen MW, Chatterjee D, Belisle JT, Fenton MJ: Chemotactic activity of mycobacterial lipoarabinomannans for human blood T lymphocytes in vitro. J Immunol 1996, 156:3828-3835. The authors provide evidence that mannose-capped LAM from M. tuberculosis as well as AraLAM could induce T-cell migration in the absence of serum using a modified Boyden chamber assay. In contrast, mannose-capped LAM from M. bovis BCG failed to induce this effect. Chemotaxis was dependent upon the acyl groups of LAM, new protein synthesis and protein tyrosine kinases. Experiments using human alveolar macrophages indicated that LAM may be one of the chemotactic factors released by M. tuberculosis-infected macrophages.
47. Sieling PA, Chatterjee D, Porcelli SA, Prigozy TI, Mazzacaro RJ, Soriano T, Bloom BR, Brenner MB, Kronenberg M, Brennan PJ et al. CD1-restricted T cell recognition of microbial lipoglycan antigens. Science 1995, 269:227-230.
48. McDonough KA, Kress Y: Cytotoxicity for lung epithelial cells is a virulence-associated phenotype of Mycobacterium tuberculosis. Infect Immun 1995, 63:4802-4811.
49. Bermudez LE, Goodman J: Mycobacterium tuberculosis invades and replicates within type II alveolar cells. Infect Immun 1996, 64:1400-1406.
50. Mehta PK, King CH, White EH, Murtagh JJ Jr, Quinn FD: Comparison of in vitro models for the study of Mycobacterium tuberculosis invasion and intracellular replication. Infect Immun 1996, 64:2673-2679.